رجوع
34
25
28
60
55
نطاق اليوم
KWD 65.54
KWD 68.09
نطاق 52 أسبوعًا
KWD 54.11
KWD 89.98
حجم التداول
2,886,636
متوسط 50 يوم / 200 يوم
KWD 70.43
/
KWD 72.55
الإغلاق السابق
KWD 66.60
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 31.2 | 0.2 |
| P/B | 9.5 | 3.0 |
| ROE % | 34.5 | 3.6 |
| Net Margin % | 17.9 | 3.8 |
| Rev Growth 5Y % | 17.5 | 9.9 |
| D/E | 0.5 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 85.82
+28.4%
Low: KWD 72.00
High: KWD 95.00
مكرر الربحية المستقبلي
26.85
ربحية السهم المستقبلية
KWD 2.49
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
5.23B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 4.87
KWD 4.78 – KWD 5.07
|
8.44B | 2 |
| FY2029 |
KWD 4.19
KWD 4.11 – KWD 4.36
|
7.40B | 4 |
| FY2028 |
KWD 3.57
KWD 3.19 – KWD 3.97
|
6.56B | 6 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | KWD 0.65 | KWD 0.68 | +4.6% |
| 2025-10-30 | KWD 0.58 | KWD 0.61 | +5.9% |
| 2025-07-30 | KWD 0.44 | KWD 0.48 | +8.2% |
| 2025-05-01 | KWD 0.33 | KWD 0.32 | -2.2% |
| 2025-02-13 | KWD 0.48 | KWD 0.45 | -6.1% |
| 2024-10-24 | KWD 0.44 | KWD 0.45 | +2.3% |
| 2024-07-25 | KWD 0.39 | KWD 0.43 | +10.3% |
| 2024-04-25 | KWD 0.27 | KWD 0.32 | +18.5% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 17.47% annually over 5 years — strong growth
Earnings grew 45.14% over the past year
ROE of 34.50% indicates high profitability
Net margin of 17.94% shows strong profitability
Generating 1.08B in free cash flow
P/E of 31.17 — premium valuation
النمو
Revenue Growth (5Y)
17.47%
Revenue (1Y)15.60%
Earnings (1Y)45.14%
FCF Growth (3Y)45.06%
الجودة
Return on Equity
34.50%
ROIC16.54%
Net Margin17.94%
Op. Margin19.56%
الأمان
Debt / Equity
0.51
Current Ratio1.88
Interest Coverage0.00
التقييم
P/E Ratio
31.17
Forward P/E26.85
P/B Ratio9.49
EV/EBITDA29.11
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 15.60% | Revenue Growth (3Y) | 13.45% |
| Earnings Growth (1Y) | 45.14% | Earnings Growth (3Y) | 24.27% |
| Revenue Growth (5Y) | 17.47% | Earnings Growth (5Y) | 40.13% |
| Profitability | |||
| Revenue (TTM) | 4.66B | Net Income (TTM) | 836.30M |
| ROE | 34.50% | ROA | 13.19% |
| Gross Margin | 60.10% | Operating Margin | 19.56% |
| Net Margin | 17.94% | Free Cash Flow (TTM) | 1.08B |
| ROIC | 16.54% | FCF Growth (3Y) | 45.06% |
| Safety | |||
| Debt / Equity | 0.51 | Current Ratio | 1.88 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 31.17 | Forward P/E | 26.85 |
| P/B Ratio | 9.49 | P/S Ratio | 5.59 |
| PEG Ratio | 0.66 | Forward PEG | N/A |
| EV/EBITDA | 29.11 | Fwd EV/EBITDA | 14.46 |
| Forward P/S | 4.99 | Fwd Earnings Yield | 3.72% |
| FCF Yield | 4.13% | ||
| Market Cap | 26.07B | Enterprise Value | 26.54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.66B | 4.03B | 3.62B | 2.91B | 2.45B |
| Net Income | 836.30M | 576.20M | 541.50M | 341.20M | 216.90M |
| EPS (Diluted) | 2.09 | 1.42 | 1.30 | 0.80 | 0.51 |
| Gross Profit | 2.80B | 2.44B | 2.29B | 1.88B | 1.68B |
| Operating Income | 911.80M | 600.00M | 597.70M | 391.20M | 265.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.34B | 6.48B | 6.26B | 5.39B | 4.93B |
| Total Liabilities | 3.59B | 4.38B | 4.20B | 3.26B | 2.89B |
| Shareholders' Equity | 2.75B | 2.10B | 2.07B | 2.13B | 2.04B |
| Total Debt | 1.39B | 2.59B | 2.59B | 2.15B | 2.16B |
| Cash & Equivalents | 917.70M | 606.10M | 566.30M | 642.30M | 1.05B |
| Current Assets | 4.03B | 4.30B | 4.43B | 3.67B | 3.68B |
| Current Liabilities | 2.14B | 2.93B | 1.56B | 1.84B | 720.80M |
درجات الاستراتيجيات
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#752 of 1049
Custom
Capital Light Compounder
#183 of 220
#142 of 158
Custom
Balanced Risk
#25 of 153
Custom
Lower Risk
#27 of 141
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Capital Light Compounder
Mar 24, 2026
دخل
Growth Investing (Philip Fisher)
Mar 24, 2026
دخل
Balanced Risk
Mar 24, 2026
دخل
Lower Risk
Mar 24, 2026